TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05443282

Intervention type: DIAGNOSTIC_TEST
Intervention: Prolidase Level
Description: Measurement of venous blood serum level of prolidase enzyme level by ELISA method.

Intervention type: DIAGNOSTIC_TEST
Intervention: Prolidase Level
Description: Measurement of venous blood serum level of prolidase enzyme level by ELISA method.

Intervention type: DIAGNOSTIC_TEST
Intervention: Follicle Stimulating Hormone Level
Description: Measurement of venous blood serum level of follicle stimulating hormone level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Follicle Stimulating Hormone Level
Description: Measurement of venous blood serum level of follicle stimulating hormone level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Estradiol Level
Description: Measurement of venous blood serum level of estradiol hormone level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Estradiol Level
Description: Measurement of venous blood serum level of estradiol hormone level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Proline Level
Description: Measurement of venous blood serum level of proline level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Proline Level
Description: Measurement of venous blood serum level of proline level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Hydroxyproline Level
Description: Measurement of venous blood serum level of hydroxyproline level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Hydroxyproline Level
Description: Measurement of venous blood serum level of hydroxyproline level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Anti-mullerian Hormone Level
Description: Measurement of venous blood serum level of anti-mullerian hormone level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Anti-mullerian Hormone Level
Description: Measurement of venous blood serum level of anti-mullerian hormone level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Antral Follicle Count
Description: Ultrasonographic evaluation of antral follicle count to determine ovarian reserve.

Intervention type: DIAGNOSTIC_TEST
Intervention: Antral Follicle Count
Description: Ultrasonographic evaluation of antral follicle count to determine ovarian reserve.

Intervention type: DIAGNOSTIC_TEST
Intervention: Prolactine Level
Description: Measurement of venous blood serum prolactine hormone level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Prolactine Level
Description: Measurement of venous blood serum prolactine hormone level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Thyroid Stimulating Hormone Level
Description: Measurement of venous blood serum thyroid stimulating hormone level.

Intervention type: DIAGNOSTIC_TEST
Intervention: Thyroid Stimulating Hormone Level
Description: Measurement of venous blood serum thyroid stimulating hormone level.
Study: NCT06467669

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wrist denervation procedure
Description: To summarize, a Wagner incision is made starting over the junction of the glabrous and non-glabrous skin overlying the thumb CMC joint extending toward the distal wrist crease. The branches of the superficial radial nerve are identified as lying perpendicular to the plane overlying the fascia of the thenar muscles. The branches of the lateral antebrachial cutaneous nerve are identified and resected within the anatomic snuffbox deep to the first compartment. Finally, the thenar muscle fibers are divided at their proximal origin to identify the articular branches of the posterior cutaneous branch of the median nerve.
Study: NCT05506813

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cognitive training and conventional training
Description: cognitive training along with conventional therapy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: motor dual task training along with conventional therapy
Description: motor dual task training along with conventional therapy
Study: NCT06250712

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continous ECG Patch
Description: Using a continuous patch ECG for 1 week during 1 month

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intermittent handheld ECG
Description: Using a handheld ECG twice daily and when symptoms are present during 1 month
Study: NCT06390293

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group-delivered guided written exposure therapy-revised version
Description: Group-Delivered guided WET-R is a manualized exposure-based therapy program consisting of 5-8 sequential sessions. The interval between every 2 consecutive sessions is 0-2 days. There will be 5-8 group-delivered sessions in total (only one index trauma will be discussed), and 1-2 weeks to complete. The first and last sessions are scheduled to last for 1.5 hours each, while the other sessions will be 50 minutes in duration.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Waiting-List (WL) condition
Description: Participants assigned to WL will be asked to not work with other therapists or seek additional treatment for trauma-related difficulties during the 2-week WL period. After the one-month follow-up of the WET-R group, they will receive the same treatment (Group-Delivered guided written exposure therapy-revised version).WL participants will also be given contact information to use in case of worsening symptoms or increasing distress.
Study: NCT05868408

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Formula
Description: Infant formula made with intact protein - minimum 1.8g protein/100kcal

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Formula 1
Description: Infant formula made with hydrolyzed protein - minimum 1.9g protein/100kcal

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Formula 2
Description: Infant formula made with hydrolyzed protein - minimum 1.9g protein/100kcal
Study: NCT05543122

Intervention type: DRUG
Intervention: either of Atenolol, Bupropion, Brivaracetam, Escitalopram, Fluconazole, Lacosamide, Lamotrigine, Levetiracetam, Methotrexate or Ezetimibe
Description: This is a cohort study of pharmacokinetics of drugs in milk. Participants in the group are those breastfeeding women on the listed drugs at steady state, who are prescribed these drugs for clinical reasons outside this study framework.
Study: NCT04963933

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nautilus endovascular device
Description: Patients will be treated with the Nautilus Endovascular device followed by treatment follow up for up to 6 months
Study: NCT05105061

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine (Ketalar)
Description: 0.5 mg/kg of body weight

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ketamine (Ketalar)
Description: 0.5 mg/kg of body weight

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: IM injection of matching placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: IM injection of matching placebo
Study: NCT04961554

Intervention type: OTHER
Intervention: loco-regional anesthesia
Description: demonstrate that the mouth opening (measured in millimeters) of a patient treated for mandibular surgery with a very limited opening (defined by a threshold less than 20mm, not allowing the passage of a video laryngoscope blade per route buccal) is more important after locoregional anesthesia of the V3 than before anesthesia.
Study: NCT06388863

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Healthy donor-derived FMT capsule
Description: Participants will be treated with healthy donor-derived fecal microbiota transplantation in the form of oral capsules.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsule
Description: Capsules whose appearance and smell are identical as FMT capsules but contain milk powder
Study: NCT05829486

Intervention type: PROCEDURE
Intervention: gastroscopy
Description: anaesthetic management of ambulatory endoscopic procedures

Intervention type: PROCEDURE
Intervention: gastroscopy
Description: anaesthetic management of ambulatory endoscopic procedures
Study: NCT06258772

Intervention type: DRUG
Intervention: Mepolizumab Auto-Injector
Description: Mepolizumab 100 mg in pre-filled injector
Study: NCT06039540

Intervention type: DRUG
Intervention: Captopril Tablets
Description: 0.3mg/kg, tid

Intervention type: DRUG
Intervention: Metoprolol Oral Tablet
Description: 0.2mg/kg, bid

Intervention type: DRUG
Intervention: Spironolactone Tablets
Description: 2-4mg/kg, bid

Intervention type: DRUG
Intervention: Torsemide Tablets
Description: 0.2-0.5mg/mg, bid

Intervention type: DRUG
Intervention: Torsemide Tablets
Description: 0.2-0.5mg/mg, bid

Intervention type: DRUG
Intervention: Potassium citrate powder
Description: 0.06g/kg, tid

Intervention type: DRUG
Intervention: Potassium citrate powder
Description: 0.06g/kg, tid
Study: NCT03748654

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Visual Field Testing
Description: Visual field test using the protocol 24-2 Threshold Test
Study: NCT04896840

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation İntervention, Motor learning
Description: Telerehabilitation İntervention:~Training videos will be sent to the families of the children in the tele-rehabilitation group before starting to work. With the training videos, it is aimed to teach the exercises to be done to the families. Treatment will be applied by their families for 8 weeks, 2 days a week, 40 minutes a day. Physiotherapist will attend the sessions by video conference method. Video conference calls will be made by phone over the WhatsApp application.~Motor learning:~The first 10 minutes will start with active stretching Functional lying in a sitting position, Functional lying with feet together in a standing position. rolling the pilates ball on the wall, walking on its side. Going up and down stairs at different heights. Walking across different surfaces and obstacles. Getting up from chairs of different heights, sitting and extending the object taken from the ground. Functional exercises suitable for the child's level.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation İntervention, Motor learning
Description: Telerehabilitation İntervention:~Training videos will be sent to the families of the children in the tele-rehabilitation group before starting to work. With the training videos, it is aimed to teach the exercises to be done to the families. Treatment will be applied by their families for 8 weeks, 2 days a week, 40 minutes a day. Physiotherapist will attend the sessions by video conference method. Video conference calls will be made by phone over the WhatsApp application.~Motor learning:~The first 10 minutes will start with active stretching Functional lying in a sitting position, Functional lying with feet together in a standing position. rolling the pilates ball on the wall, walking on its side. Going up and down stairs at different heights. Walking across different surfaces and obstacles. Getting up from chairs of different heights, sitting and extending the object taken from the ground. Functional exercises suitable for the child's level.
Study: NCT06228365

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: use of a device incorporating virtual reality software
Description: use of a device incorporating virtual reality software

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neuroleptanalgesia
Description: Usual neuroleptanalgesic treatment
Study: NCT05794074

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: luteine
Description: luteine

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: zeaxanthine
Description: zeaxanthine

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT04913532

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Hypofractionation with simultaneous integrated boost
Description: Hypofractionation with simultaneous integrated boost
Study: NCT04914702

Intervention type: DEVICE
Intervention: Everion®
Description: The Everion® is an on-skin wearable devices measuring vital signs. It will be given to the participants for the duration of 2 weeks (fourteen days) with the instruction to wear all the time, with exception of the time needed for the patients' hygiene.

Intervention type: DEVICE
Intervention: Everion®
Description: The Everion® is an on-skin wearable devices measuring vital signs. It will be given to the participants for the duration of 2 weeks (fourteen days) with the instruction to wear all the time, with exception of the time needed for the patients' hygiene.

Intervention type: DEVICE
Intervention: Everion®
Description: The Everion® is an on-skin wearable devices measuring vital signs. It will be given to the participants for the duration of 2 weeks (fourteen days) with the instruction to wear all the time, with exception of the time needed for the patients' hygiene.
Study: NCT05852223

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Neoadjuvant pembrolizumab 200mg Q3W will be administered via IV infusion for 2 courses from the date of randomization until to the date of thyroidectomy.
Study: NCT04914702

Intervention type: DEVICE
Intervention: Everion®
Description: The Everion® is an on-skin wearable devices measuring vital signs. It will be given to the participants for the duration of 2 weeks (fourteen days) with the instruction to wear all the time, with exception of the time needed for the patients' hygiene.

Intervention type: DEVICE
Intervention: CORE®
Description: The CORE® is an on-skin wearable devices measuring vital signs. It will be given to the participants for the duration of 2 weeks (fourteen days) with the instruction to wear all the time, with exception of the time needed for the patients' hygiene.

Intervention type: DEVICE
Intervention: CORE®
Description: The CORE® is an on-skin wearable devices measuring vital signs. It will be given to the participants for the duration of 2 weeks (fourteen days) with the instruction to wear all the time, with exception of the time needed for the patients' hygiene.

Intervention type: DEVICE
Intervention: CORE®
Description: The CORE® is an on-skin wearable devices measuring vital signs. It will be given to the participants for the duration of 2 weeks (fourteen days) with the instruction to wear all the time, with exception of the time needed for the patients' hygiene.
Study: NCT05301595

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TAP block
Description: Please see description of TAP block group.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: QL Block
Description: Please see description of QL block group.
Study: NCT05263830

Intervention type: OTHER
Intervention: Quantitative assay of GlypicanPC-3
Description: Quantitative assay of GlypicanPC-3 in human serum is performed by direct sandwich immunoassay ( CanAg Glypican3 EIA - Fujirebio ) on microplate using two mouse monoclonal antibodies against two epitopes of the Glypican-3 core protein
Study: NCT05308628

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Liver Allograft Fibrosis by Using Fibrosis Panel(PRO-C3, PIIINP, TIMP-1, HA etc.)
Description: Liver biopsies will be performed at 3 months, 6 months and 12 months post-transplant. Fibrosis was evaluated using the liver allograft fibrosis score (LAFSc) staging system. Liver Allograft Fibrosis by Using Fibrosis Panel(PRO-C3, PIIINP, TIMP-1, HA)or (FBLN3,YKL40,LECT2 etc.)

Intervention type: DIAGNOSTIC_TEST
Group type: SHAM_COMPARATOR
Intervention: Liver Allograft Fibrosis by Using Fibrosis Panel(PRO-C3, PIIINP, TIMP-1, HA etc.)
Description: Liver biopsies will be performed at 3 months, 6 months and 12 months post-transplant. Fibrosis was evaluated using the liver allograft fibrosis score (LAFSc) staging system. Liver Allograft Fibrosis by Using Fibrosis Panel(PRO-C3, PIIINP, TIMP-1, HA)or (FBLN3,YKL40,LECT2 etc.)
Study: NCT04914702

Intervention type: DEVICE
Intervention: CORE®
Description: The CORE® is an on-skin wearable devices measuring vital signs. It will be given to the participants for the duration of 2 weeks (fourteen days) with the instruction to wear all the time, with exception of the time needed for the patients' hygiene.
Study: NCT06151106

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide combined with Duvillisib
Description: Specified dose on specified days
Study: NCT05889494

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Autologous Whole Blood Management
Description: Intraoperative high volume autologous whole blood withdrawal with re-transfusion following weaning from CPB.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care involving allogenic and/or derivative transfusion.
Description: Therapeutic treatment of CPB-induced coagulopathy using donated allogenic blood products including plasma, platelets, and cryoprecipitate and/or derivative administration using prothrombin complex and fibrinogen concentrates.
Study: NCT06425965

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Advanced life support training with high reality simulator
Description: The training consists of theoretical and practical training and lasts 3 hours a day, 5 days, for a total of 15 hours. The first 3 days of the training are theoretical, 1 day is laboratory practice and 1 day is evaluation. Theoretical courses start with introductions and sharing the content of the training and aim to provide the basic professional knowledge and skills required for advanced life support practice (diagnosis of cardiac arrest, ensuring airway patency, monitoring, cardiac rhythm diagnosis, drugs used during advanced life support and advanced life support algorithm). The laboratory application of the training is carried out with a high reality simulator in line with the information (15 min), scenario implementation (15 min) and debriefing sessions (30 min), respectively.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Advanced life support training with web-based simulation
Description: The training consists of theoretical and practical training and lasts 3 hours a day, 5 days, for a total of 15 hours. The first 3 days of the training are theoretical, 1 day is laboratory practice and 1 day is evaluation. Theoretical courses start with introductions and sharing the content of the training and aim to provide the basic professional knowledge and skills required for advanced life support practice (diagnosis of cardiac arrest, ensuring airway patency, monitoring, cardiac rhythm diagnosis, drugs used during advanced life support and advanced life support algorithm). The laboratory application of the training is carried out by web-based simulation method. Students participate in the web-based simulation application developed by the researcher.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Advanced life support training with hybrid simulation
Description: The training consists of theoretical and practical training and lasts 3 hours a day, 5 days, for a total of 15 hours. The first 3 days of the training are theoretical, 1 day is laboratory practice and 1 day is evaluation. Theoretical courses start with introductions and sharing the content of the training and aim to provide the basic professional knowledge and skills required for advanced life support practice (diagnosis of cardiac arrest, ensuring airway patency, monitoring, cardiac rhythm diagnosis, drugs used during advanced life support and advanced life support algorithm). The laboratory application of the training is carried out with the hybrid simulation method in which high reality simulator and web-based simulation method are applied together. Students first apply the web-based simulation developed by the researcher. Then they perform the practice on the high reality simulator.
Study: NCT05713084

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: mandibular setback using BSSRO
Description: mandibular setback using BSSRO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mandibular setback using BSSRO
Description: mandibular setback using BSSRO
Study: NCT05510882

Intervention type: OTHER
Group type: OTHER
Intervention: different treatment modalities for OSA
Description: Group I: patients will be treated with CPAP. Group II: patients will be treated with digitally fabricated MAD. Group II: patients will be treated with physical therapy.
Study: NCT04938999

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music-visual guided physical activity (MVgPA)
Description: The MVgPA adopts the information-motivation-strategy model to address the personal and environmental challenges in PA initiation and maintenance of adults with intellectual disability.~To support the staff of residential care facilities in implementing 24 sessions of MVgPA in 12 weeks, the first six sessions will be led by the RA1 and co-facilitated by the staff, while the subsequent sessions will be conducted by the staff only. At week 6, another set of MVgPA will be implemented to increase the participant's interest; two sessions will be co-facilitated by RA1. At weeks 6 and 9, the RN and RA1 will hold a meeting with the staff of the residential care facilities to acknowledge the achievement of the staff and adults with ID, as well as to address any of their concerns related to the implementation of MVgPA, and to identify the facilitators and tackle barriers to the implementation of the MVgPA.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Usual care
Description: As control group, residential care facilities will conduct their usual activities during the study period. A trained RA will record the activities conducted by the residential care facilities during the study period.
Study: NCT05579873

Intervention type: PROCEDURE
Intervention: Clavicle plating
Description: VariAx 2.0mm + 2.4 or 2.7mm vs any other single plate

Intervention type: PROCEDURE
Intervention: Clavicle plating
Description: VariAx 2.0mm + 2.4 or 2.7mm vs any other single plate
Study: NCT05818761

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: virtual reality
Description: wearing virtual reality glasses

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: stress ball
Description: squeezing the stress ball during the attempt
Study: NCT05890378

Intervention type: OTHER
Intervention: Testing water
Description: Using existing secondary data available on the research communities as well as qualitative inquiry, we will purposefully select 40 water sources for the water analysis across from the communities selected for the implementation research (up to 30 communities with a maximum of 5 water sources per community). The selection of water sources will be stratified by type of water sourceand near the route for long-term animal migration. For each water source, we will aim to have a water sample collected at all water sources twice a day (morning and later afternoon) once a week for four weeks, varying the day of the week. Thus, we will collect a total of 320 water samples in the course of four weeks at the end of the dry season before the rains start.